Emergency Total ECLS Should Not Be Routinely Used Over Standard ACLS with Rescue ECMO for Refractory OHCA
Based on the most recent high-quality evidence, emergency total extracorporeal life support (ECLS) should not be routinely implemented for witnessed out-of-hospital cardiac arrest; instead, standard ACLS with selective rescue ECMO may be considered only in highly selected patients within established ECMO programs that can achieve strict time targets. 1
Evidence Summary: Conflicting RCT Results
The recommendation against routine emergency ECLS is driven by conflicting randomized trial data:
Trials Showing No Benefit
The INCEPTION trial (2024) - the most recent multicenter RCT - found no significant difference in 30-day survival with favorable neurological outcome between eCPR (20.0%) versus standard ACLS (16.1%), P=0.52 1. Critically, this trial revealed longer median times from cannulation to ECMO flow initiation compared to positive trials, suggesting that real-world implementation challenges diminish effectiveness 1.
The Hyperinvasive Approach trial similarly showed no statistically significant difference in 180-day survival with good neurological outcome: eCPR 31.5% vs standard ACLS 22.0% (P=0.09). This trial was terminated early for futility, and notably demonstrated higher bleeding risk with eCPR (31.0% vs 14.5%) 1.
Single Positive Trial with Major Limitations
Only the ARREST trial showed superiority (42.9% vs 6.7% survival to discharge), but this was a small single-center study of just 30 patients that was terminated early 1. The dramatic difference in control group outcomes between ARREST (6.7% survival) and Hyperinvasive (22% survival) suggests the ARREST control group may have been unusually poor, limiting generalizability 2.
Current Guideline Recommendations
2024 Canadian Cardiovascular Society Expert Opinion
"eCPR should not be routinely used, but may be considered in highly selected patients with refractory cardiac arrest (>5-15 minutes) with limited comorbidities and a witnessed cardiac arrest with a targeted cardiac arrest to cannulation time of <60 minutes." 1
2025 American Heart Association Guidelines
The AHA acknowledges ECLS "is reasonable" in select cases but emphasizes this applies only to "disease processes" with potentially reversible etiologies and requires specialized systems 3.
2024 AHA Focused Update
Provides a weak recommendation with low-certainty evidence that ECPR "may be considered as a rescue therapy for selected adults" only "in settings where this can be implemented" 2.
When to Consider Rescue ECMO (Not Emergency Total ECLS)
If considering ECMO at all, the approach should be standard ACLS first with selective rescue ECMO, not immediate emergency ECLS. Consider only when ALL criteria are met:
Patient Selection Criteria
- Age 18-70 years (some protocols extend to 75) 1
- Witnessed cardiac arrest of presumed cardiac origin 1
- Shockable rhythm (VF/pulseless VT) - evidence for non-shockable rhythms is even weaker 1
- Bystander CPR initiated 1
- Refractory arrest defined as >5-15 minutes of ACLS without ROSC 1
- Limited comorbidities - exclude terminal malignancy, severe neurologic damage, poor baseline functional status 1, 4
Absolute Exclusions
- Trauma or burn-related injury 1
- Drowning 1
- Known overdose 1
- Suspected pregnancy 1
- Known severe chronic organ dysfunction 1
- Bleeding diathesis or recent intracranial bleeding 1
- Valid do-not-resuscitate order 1
Critical Time Targets (Must Be Achievable)
- Cardiac arrest to cannulation time: <60 minutes 1
- Hospital arrival to cannulation time: <30 minutes 1
If these time targets cannot be reliably achieved, ECMO should not be offered - the INCEPTION trial's failure likely reflects inability to meet these benchmarks in multicenter settings 1.
System Requirements
Only Consider in Centers With:
- Established venoarterial ECMO programs with proven track record 1
- Formalized integrated eCPR clinical pathways 1
- 24/7 availability of trained cannulation team 1
- Immediate access to cardiac catheterization lab for coronary angiography 1
- Multidisciplinary post-arrest care capabilities 1
Common Pitfalls to Avoid
Do not implement emergency total ECLS protocols based solely on the ARREST trial - this single-center study's results have not been replicated in multicenter settings 1, 2.
Do not offer ECMO if time targets cannot be met - delayed cannulation eliminates any potential benefit and exposes patients to significant bleeding and vascular complications 1.
Do not use ECMO for non-shockable rhythms - evidence is insufficient and outcomes are particularly poor 5.
Do not overlook the resource intensity - ECMO is costly, requires specialized equipment and training, and diverts resources from other critically ill patients 6.
The Bottom Line
The weight of evidence from the most recent multicenter RCT (INCEPTION 2024) and the futility-terminated Hyperinvasive trial demonstrates that emergency total ECLS does not improve outcomes over standard ACLS with selective rescue ECMO 1. The single positive ARREST trial represents an outlier that likely reflects exceptional single-center expertise rather than generalizable practice 2.
Standard ACLS remains the foundation of refractory OHCA management, with rescue ECMO reserved as a highly selective intervention in experienced centers that can achieve aggressive time targets for a narrow subset of patients with witnessed shockable-rhythm arrests 1, 2.